Abstract. The degradation of angiotensin II ( Asp1\ x=r eq-\ Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8: A-II) by human placental particulate and soluble fractions, pregnant and non-pregnant sera, and highly purified placental enzymes such as placental leucine aminopeptidase P-LAP (microsomal), retroplacental serum P-LAP (soluble), aminopeptidase A and post-proline endopeptidase, was studied by measuring liberated amino acids by high performance liquid chromatography. Placental 
pletely into single amino acids. The purified P-LAP (microsomal) actively liberated five amino acids from the N-terminal. The placental particulate fraction containing P-LAP (microsomal) also actively liberated these amino acids. The purified aminopeptidase A liberated Asp1 very actively as expected. When the ratio of the velocity of liberation of each amino acid to P-LAP activity measured with leu-p-nitroanilide as a substrate was calculated, placental soluble fraction liberated Asp1 very actively, but the liberation rate of Asp1 with the purified P-LAP (soluble) was very low. Therefore it seems that the enzyme in the placental soluble fraction and pregnancy serum responsible for the Asp1 liberation is not P-LAP (soluble), but aminopeptidase A. The mixture of purified P-LAP (soluble) and aminopeptidase A showed higher liberation rate of Arg2 and Val3 than that with purified aminopeptidase A alone, demonstrating that once the N-terminal Asp1 was liberated, the P-LAP (soluble) attacks the shorter peptide (angiotension III) very actively.
It was concluded that P-LAP (microsomal) together with aminopeptidase A seem to contribute greatly to the degradation of A-II in pregnant women.
The concentration of angiotensin II (Asp'-Arg2-Val3-Tyr4-Iles-His6-Pro7-Phe8: A-II) in the serum of pregnant women is higher than that in nonpregnant women (Weir et al. 1973 ). The highest concentration of the hormone can be found in arterial cord blood (Vallotton et al. 1976 ). The higher concentration of A-II in arterial cord blood than in venous cord blood suggests that A-II is generated mainly in the foetus itself and partly destroyed within the placenta. It is easy to infer that the inactivation of A-II is also enhanced during pregnancy under the conditions of in¬ creased A-II production.
Despite studies on the metabolism of A-II in rat tissues (Regoli et al. 1963; Tonnaer et Purification ofenzymes P-LAP (soluble), P-LAP (microsomal), aminopeptidase A and post-proline endopeptidase were purified according to our methods described elsewhere Mizutanietal. 1981 Mizutanietal. , 1982 Mizutanietal. , 1984 .
Assay
Enzyme activités of P-LAP, aminopeptidase A and postproline endopeptidase were measured according to our methods (Mizutani et al. 1976 (Mizutani et al. , 1984 (Table 3 ). The ratio for Asp1 was high with the placental particulate fraction, placental soluble fraction and purified P-LAP (microsomal), whereas it was low with the purified P-LAP (soluble).
Discussion
Placental particulate and soluble fractions almost completely degraded A-II into single amino acids, although the velocity of each amino acid liberation was different (Table 2) . Tonnaer et al. (1983) showed that A-II was rapidly metabolized by rat brain synaptosomal soluble fraction, but not by membrane fraction. We previously showed that aminopeptidase A is present in human placenta and increased in preg¬ nancy sera (Mizutani et (Table 3) .
A-II degrading activity with P-LAP (soluble) pu¬ rified from retroplacental serum was low (Table 2) .
Purified P-LAP (soluble) gave a lower value than placental soluble fraction and pregnancy serum (Table 3 ). This result suggests that the high amino acid liberating activity found in the soluble fraction is not due to this enzyme, but probably due to aminopeptidase A (Table 2) .
Our study showed that the purified post-proline endopeptidase specifically hydrolyzes the C-terminal Phe8 (Table 2) . Recently, we showed that human placental post-proline endopeptidase is localized in the cytosol fraction (Mizutani et 
